Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2000

View Archived Issues

Immune Response synthesizes new factor VIII gene

Cantab makes steady progress during 1999

Reticulose cleared for clinical trials in Argentina

FDA advisory committee meeting canceled

OSI Pharmaceuticals makes forward strides during Q1 2000

NCI begins phase II trial of O6-benzylguanine/carmustine as glioma therapy

Biomira updates product pipeline

Gilead reviews progress in 1999

Oxigene to develop CA4P for eye, skin and joint disorders

Life-saving treatment for pulmonary hypertension in newborn babies featured in NEJM

New phenethylsulfones synthesized at Celgene useful for inflammation, etc.

Lilly's new 5-ht1f receptor antagonists covered by two European patents

Cell Pathways presents apoptosis-promoting compounds

Gene therapy improves age-related cardiac disorder in rats

New compounds with ampakine-like activity in development at Lilly

Novirio claims large group of HIV RT inhibitors

Cantharidin analogues as protein phosphatase inhibitors: use in cancer therapy

Antiparasitic artemisinin derivatives designed at Hong Kong university

New antiepileptic Diastat available in Canada for ARS

Early clinical trial in Japan demonstrates safety, favorable pharmacokinetics of CGS-19755

CPMP issues positive opinion regarding PEG-Intron MAA

Antifungal activity of brasilinolide B described by Japanese research team

Switch Biotech files patent applications for wound-healing genes

Approvable letter issued by FDA for Texas Biotechnology's Novastan

Paladin licenses Uniprost to United Therapeutics in Canada

Trichobitacin: anti-HIV RIP purified from Chinese medicinal herb

Monsanto and P&U to hold special shareholder meetings to vote on proposed merger

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...